Astrazeneca vaccine suspended in europe - activities

AstraZeneca/Janssen: thromboses explained by German searchers

German scientists are said to have discovered where thromboses caused by the AstraZeneca and Janssen vaccines come from, explaining they are caused by the vector used, the adenovirus. Keep reading to find out more.

AstraZeneca vaccine must remain limited to people aged 55+ by the Haute Autorité de Santé says

The Haute Autorité de Santé "maintains the limit of 55 years of age for Vaxzevria", aka AstraZeneca's vaccine, because of the benefit/risk ratio related to rare cases of thrombosis. This notice follows the government's demand as they wish to extend its access to all volunteering French as it is already happening in Germany.

AstraZeneca reviews data and announces vaccine is 76% effective

As this Monday March 22, AstraZeneca laboratory stated their vaccine was 79% effective and show no risk of thromboses (blood clots), this Thursday March 25, the Swedish-British laboratory reviewed data as required by the NIAID (National Institute of Allergy and Infections Diseases), and announced updated data including vaccine was 76% effective.

AstraZeneca vaccine: WHO advises to keep vaccinating

The World Health Organization called emergency meeting this Tuesday March 16 in Geneva and urge countries to keep on vaccinating with AstraZeneca vaccine, after several EU countries have halted vaccinating with this product, after noticing severe reactions after injection in some cases. The European Medicines Agency is also to meet this Thursday March 18 to take a stock on the situation.